ChEMBL Tour 2014 - The Netherlands, Belgium, and Luxembourg

Last year Louisa Bellis toured the UK to present on SMSdrug.net and ChEMBL. The tour was well received and a large number of people that had not heard of ChEMBL were introduced to ChEMBL.

Following the success of the previous tour, Gerard van Westen (EMBL –EBI) is going to be doing a 2014 ChEMBL tour. This year’s tour will be going to the BeNeLux. For dates and locations see below. Please feel free to attend and meet up / chat on ChEMBL, contactable via email on gerardvw [at] ebi.ac.uk

Current dates are as follows:

19th of May – Maastricht University
Host: Egon Willighagen
Time: 12.00-17.00
ChEMBL + Allosteric modulators

20th of May – Maastricht University
Host: Jos Kleinjans
Time: 09.00 - 11.30
ChEMBL + Advanced ChEMBL

20th of May – KU Leuven
Host: Pieter Annaert
Time: 14.00 -17.00
ChEMBL

21th of May – KU Leuven
Host: Piet herdewyn
Time: 09.00 -10.00
ChEMBL

21th of May – University of Luxembourg
Host: Reinhard Schneider
Time: 13.00 - 17.00
ChEMBL + Advanced ChEMBL

22nd of May – Universiteit Antwerpen
Host: Koen Augusteyns
Time: 15.00 - 17.00
ChEMBL

26th of May – VU University Amsterdam & Universiteit van Amsterdam
Hosts: Chris de Graaf & Willem Stiekema
Time: 10.00 - 15.00
ChEMBL + Allosteric modulators

28th of May – University of Groningen
Host: Alexander Domling
Time: 14.00 - 17.00
ChEMBL + Advanced ChEMBL

6th of June – Utrecht University
Host: Roland Pieters
Time: 09.00 - 12.00
ChEMBL

6th of June – Universiteit Leiden
Host: Ad IJzerman
Time: 15.30 - 17.00
ChEMBL

17th of June – Erasmus Medical Centre, Rotterdam
Host: Roland Kanaar
Time: 14.00 - 17.00
ChEMBL

18th of June – Radboud University Nijmegen
Host: Tina Ritschel
Time: 13.30 - 15.00
ChEMBL + Allosteric modulators

Comments

Andy said…

I wish you a good trip, Gerard, and may you further increase the fame and glory of ChEMBL :-)! All the best, Andreas

27 May 2014 at 11:52

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Legacy SureChEMBL retirement

Dear SureChEMBL users, About six months ago, we introduced the new version of SureChEMBL . It brought significant improvements in terms of performance and stability, and it also allows us to implement new functionalities. After the survey at the beginning of the year, we prioritised what should be delivered first. You should see the materialisation of our work in the coming months. As originally announced when the new SureChEMBL was introduced, the plan was to shut down the old system permanently to focus all our resources on the new SureChEMBL. This time has come, so expect www.surechembl-legacy.org to be unreachable in the coming days with no turning back! Consequently, and in parallel, the new SureChEMBL will lose its Beta status, and we will stop referring to it as the new version. This does not mean we are reducing our efforts to improve our system; on the contrary, this removes a distraction! If you have any feedback, you can contact us directly at surechembl-help@ebi.ac.uk . W

ChEMBL & SureChEMBL anniversary symposium

In 2024 we celebrate the 15th anniversary of the first public release of the ChEMBL database as well as the 10th anniversary of SureChEMBL. To recognise this important landmark we are organising a two-day symposium to celebrate the work achieved by ChEMBL and SureChEMBL, and look forward to its future. Save the date for the ChEMBL 15 Year Symposium October 1-2, 2024 Day one will consist of four workshops, a basic ChEMBL drug design workshop; an advanced ChEMBL workshop (EUbOPEN community workshop); a ChEMBL data deposition workshop; and a SureChEMBL workshop. Day two will consist of a series of talks from invited speakers, a few poster flash talks, a local nature walk, as well as celebratory cake. During the breaks, the poster session will be a great opportunity to catch up with other users and collaborators of the ChEMBL resources and chat to colleagues, co-workers and others to find out more about how the database is being used. Lunch and refreshments will be pro

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains: 2,431,025 compounds (of which 2,409,270 have mol files) 3,106,257 compound records (non-unique compounds) 20,772,701 activities 1,644,390 assays 15,598 targets 89,892 documents Data can be downloaded from the ChEMBL FTP site: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d

The ChEMBL-og

Search This Blog